Drug Type Synthetic peptide |
Synonyms- |
Action- |
Mechanism CDK4 inhibitors(Cyclin-dependent kinase 4 inhibitors), CDK6 inhibitors(Cyclin-dependent kinase 6 inhibitors), ENaC blockers(Epithelial sodium channel blockers) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Immune System Diseases | Discovery | - | 02 Feb 2023 | |
| Immune System Diseases | Discovery | - | 02 Feb 2023 | |
| Immune System Diseases | Discovery | - | 02 Feb 2023 | |
| Neoplasms | Discovery | - | 02 Feb 2023 | |
| Neoplasms | Discovery | - | 02 Feb 2023 | |
| Neoplasms | Discovery | - | 02 Feb 2023 | |
| Respiratory Diseases | Discovery | - | 02 Feb 2023 | |
| Respiratory Diseases | Discovery | - | 02 Feb 2023 | |
| Respiratory Diseases | Discovery | - | 02 Feb 2023 | |
| Sepsis | Discovery | - | 02 Feb 2023 |





